Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 9
Submit an article Journal homepage
731
Views
41
CrossRef citations to date
0
Altmetric
Original Article

Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study

Andreas GeierDivision of Hepatology, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; ;Department of Gastroenterology & Hepatology, University Hospital Zurich, Zurich, Switzerland; Correspondence[email protected]
View further author information
,
Mareile EichingerClinical Trials Center, University Hospital Zurich, Zurich, Switzerland; View further author information
,
Guido StirnimannUniversity Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; View further author information
,
David SemelaDepartment of Gastroenterology & Hepatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; View further author information
,
Fabian TayClinical Trials Center, University Hospital Zurich, Zurich, Switzerland; View further author information
,
Burkhardt SeifertDepartment of Biostatistics at Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland; View further author information
,
Oliver TschoppDepartment of Endocrinology and Diabetology, University Hospital and University of Zurich, Zurich, Switzerland; View further author information
,
Heike BantelDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; View further author information
,
Daniel JahnDivision of Hepatology, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; View further author information
,
Ewerton Marques MaggioDepartment of Pathology, University Hospital Zurich, Zurich, Switzerland; View further author information
,
Lanja SalehDepartment of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland; View further author information
,
Heike A. Bischoff-FerrariDepartment of Geriatrics and Aging Research, University of Zurich, SwitzerlandView further author information
,
Beat MüllhauptDepartment of Gastroenterology & Hepatology, University Hospital Zurich, Zurich, Switzerland; View further author information
&
Jean-François DufourClinical Trials Center, University Hospital Zurich, Zurich, Switzerland; View further author information
 show all
Pages 1114-1120 | Received 09 May 2018, Accepted 10 Jul 2018, Published online: 29 Sep 2018

References

  • Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.
  • Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577–1586.
  • Geier A, Rau M. Emerging therapies for NASH – the future is now. Expert Rev Clin Pharmacol. 2017;10(5):467–469.
  • Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 201410(1):CD007470.
  • Nelson JE, Roth CL, Wilson LA, et al. Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-kappaB? Am J Gastroenterol. 2016;111(6):852–863.
  • Nakano T, Cheng YF, Lai CY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol. 2011;55(2):415–25.
  • Forouhi NG, Luan J, Cooper A, et al. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57(10):2619–2625.
  • Hypponen E, Boucher BJ, Berry DJ, et al. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008;57(2):298–305.
  • Dasarathy J, Periyalwar P, Allampati S, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34(6):e118–e127.
  • Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009;139(2):329–334.
  • Gannage-Yared MH, Chedid R, Khalife S, et al. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009;160(6):965–971.
  • Bedossa P, Poitou C, Veyrie N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56(5):1751–1759.
  • Bantel H, Lugering A, Heidemann J, et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology. 2004;40(5):1078–1087.
  • Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321.
  • Ratziu V, Giral P, Jacqueminet S, et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology. 2008;135(1):100–110.
  • Amin HL, Agah S, Mousavi SN, et al. Regression of non-alcoholic fatty liver by vitamin D Supplement: a double-blind randomized controlled clinical trial. Arch Iran Med. 2016 Sep;19(9):631–638.
  • Sharifi N, Amani R, Hajiani E, et al. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 2014;47(1):70–80.
  • Beilfuss J, Berg V, Sneve M, et al. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012;60(3):870–874.
  • Papapostoli I, Lammert F, Stokes CS. Effect of short-term vitamin d correction on hepatic steatosis as quantified by controlled attenuation parameter (CAP). J Gastrointestin Liver Dis. 2016;25(2):175–181.
  • Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010;21(7):1121–1132.
  • Ross AC, Taylor CL, Yaktine AL, et al., editors. Dietary reference intakes for calcium and vitamin D. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC); 2011.
  • Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med. 201010;170(9):813–820.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.